Pesquisa

Edição
Título
Autores
SEXUAL REHABILITATION OF PATIENTS AFTER BRACHYTHERAPY FOR LOCALIZED PROSTATE CANCER
Gamidov S., Chepurov A., Perov R., Gamidov S., Chepurov A., Perov R.
TARGET THERAPY HER2-POSITIVE BREAST CANCER WITH BRAIN METASTASES: NEW PROSPECTS FOR TREATMENT
Yu Semiglazova T., Filatova L., Kh Latipova D., Gershanovich M., Semiglazova T., Filatova L., Khamidovna L., Gershanovich M.
PERVAYa LINIYa TERAPII METASTATIChESKOGO RAKA POChKI
Timofeev I.
KAPETsITABIN V LEChENII BOL'NYKh RAKOM ZhELUDKA
Lud A.
Chronic gastritis: diagnostics and treatment
Yakovenko E., Ivanov A., Illarionova Y., Agafonova N., Yakovenko A., Pryanishnikova A., Ivanov E., Illarionova Y., Agafonova N., Jakovenko A., Prjanishnikova A.
Analysis of pharmacotherapy in patients with HR+HER2- metastatic breast cancer with PIK3CA mutations in real clinical practice
Fateeva A., Eliseeva E., Apanasevich V., Zaemskaya A.
Clinical experience with the use of combination drug therapy in the first line treatment of metastatic non-small cell lung cancer
Ivanova F., Nikolaeva T., Spiridonova N., Afanasyeva L., Nikiforov P., Zharnikova T.
GSTT1 and GSTM1 deletion polymorphism as a predictor of response to hormonal therapy for breast cancer
Gulian I., Bystritskaya E., Otstavnykh N., Khudchenko E., Eliseeva E., Apanasevich V., Isaeva M.
Possibilities of the combination of avelumab and axitinib in the first line in patients with advanced renal cell carcinoma
Semenova A., Protsenko S., Teletaeva G., Latipova D., Novik A.
Type 3 diabetes mellitus: is there a chance to become famous?
Morgunov L.
Hope or error: can combinations of EGFR tyrosine kinase inhibitors and other drugs replace monotherapy?
Moiseenko F.
Observation of primary duodenal cancer. Case report
Khakimov G., Dzhumaniyozov K., Khakimova G.
Evaluation of the effectiveness of adjuvant chemotherapy for locally advanced gastric cancer in real clinical practice
Belyak N., Orlova R., Kutukova S., Zhukova N., Borozdina S.
Adjuvant and neoadjuvant therapy for (based on the materials of the 16th St. Gallen International Breast Cancer Conference)
Semiglazov V., Semiglazov V.
The predictive value of nutritional deficiency in the treatment of patients with locally advanced stomach cancer
Brish N., Semiglazova T., Zakharova P., Mishchenko A., Kasparov B., Protsenko S., Teletaeva G., Latipova D., Semenova A., Tkachenko E., Alekseeva Y., Ulyanchenko Y., Filatova L., Semiglazov V.
Pharmacoeconomic analysis of pembrolizumab in combination with chemotherapy as the first line of advances non-squamous nonsmall cell lung cancer treatment
Zyryanov S., Frolov M., Zhuravleva M., Rogov V., Sakaeva D.
PROSPECTIVE II PHASE STUDY ON THE EVALUATION OF THE EFFICACY OF MONOTHERAPY WITH CETUXIMAB AS THE FIRST-LINE TREATMENT FOR PATIENTS WITH METASTATIC COLORECTAL CANCER WITH WILD-TYPE KRAS, NRAS, AND BRAF GENES
Moiseenko V., Moiseenko F., Volkov N., Yanus G., Kuligina E., Sokolenko A., Aleksakhina S., Chubenko V., Kozyreva K., Abduloeva N., Kramchaninov M., Zhuravlev A., Khinshtein V., Shelekhova K., Kudryavtsev A., Myslik A., Ivantsov A., Venina A., Preobrazhenskaya E., Mityushkina N., Ievleva A., Imyanitov E.
PD-L1 EXPRESSION IN BLADDER CANCER AGAINST THE BACKGROUND OF CHRONIC HERPESVIRUS INFECTION: RESULTS OF A PILOT STUDY
Kosova I., Loran O., Sinyakova L., Gundorova L., Kosov V., Pogodina I., Kolbasov D.
New possibilities of the treatment of breast cancer: microtubule inhibitors
Semiglazov V., Dashyan G., Krivorotko P., Paltuev R., Donskikh R., Semiglazova T., Zernov K., Gigolaeva L., Apollonova V.
Basic mechanisms of resistance to egfr tyrosine kinase egfrinhibitors
Sakaeva D., Gordiev M.
Eradication of Helicobacter pylori infection as a strategy for the prevention of stomach cancer: statements of MaastrichT-V consensus (2015)
Mayev I., Andreev D., Samsonov A., Dicheva D., Zaborovsky A., Partsvania-Vinogradova E.
METASTATIC GASTRIC CANCER: DESCRIPTION OF CLINICAL CASE
Abramov M., Bardovskaya K., Mescheryakov A., Medvedeva B.
FIRST-LINE ENDOCRINE THERAPY OF HORMONE RECEPTOR-POSITIVE HER2-NEGATIVE METASTATIC BREAST CANCER. TIME OF CHANGE AFTER A LONG-TERM CALM PERIOD
Zhukova L., Manikhas A.
MODERN POSSIBILITIES OF MEDICAL TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC BLADDER CANCER
Vorontsova K., Zhukova L.
Sovremennye vozmozhnosti lecheniya bol'nykh disseminirovannym kolorektal'nym rakom: II liniya lekarstvennoy terapii -
Vorontsova K., Dobrova N., Vyshinskaya G.
NOVYY MEZhDUNARODNYY (KIOTSKIY) KONSENSUS PO VEDENIYu PATsIENTOV S GASTRITOM
Tsukanov V., Kasparov E., Vasyutin A., Onuchina E., Tonkikh Y.
Opyt lecheniya bol'nykh metastazami kolorektal'nogo raka: irinotekan+raltitreksed (2-ya liniya khimioterapii)
Vorontsova K., Dobrova N., Vakhabova Y., Vyshinskaya G.
Novye metody terapii v lechenii kastratsionnorezistentnogo raka predstatel'noy zhelezy
Sokov D.
SOVREMENNYE PODKhODY K LEKARSTVENNOY TERAPII BOL'NYKh METASTATIChESKIM KASTRATsIONNO-REFRAKTERNYM RAKOM PREDSTATEL'NOY ZhELEZY
Kaprin A., Alekseev B., Nyushko K., Kalpinskiy A.
Gormonoterapiya metatstaticheskogo i retsidivnogo raka endometriya
Bakhidze E.
NOVYE VOZMOZhNOSTI TERAPII BOL'NYKh METASTATIChESKIM RAKOM MOLOChNOY ZhELEZY, POLUChAVShIKh RANEE ANTRATsIKLINI TAKSAN-SODERZhAShchUYu KhIMIOTERAPIYu: OBZOR LITERATURY I KLINIChESKIY SLUChAY
Zhukova L.
Adjuvant therapy with trastuzumab for early-stage breast cancer: 12 or 24 months (based on ESMO data, Vienna, october, 2012)
Zhukova L., Lichinitser M.
Place of drug therapy in the prevention and treatment of bone complications of prostate cancer
Rusakov I., Kosov A., Mishugin S.
SORAFENIB V LEChENII RASPROSTRANENNOGO GEPATOTsELLYuLYaRNOGO RAKA
Bisovskaya Y., Breder V., Sekacheva M., Sletina S., Sotnikova O., Poddubskaya E., Bazin I., Gorbunova V.
COMBINATION CHEMOTHERAPY OF ADVANCED NON-SMALL-CELL LUNG CANCER BY DRUGS PACLITAXEL AND CARBOPLATIN: AN OPEN PROSPECTIVE CLINICAL TRIAL
Gorbunova V., Marenich A., Reutova E., Sheveleva L., Karaseva N., Bogdanova N., Uskov D., Khasanov R., Mukhametshina G., Tuzikov S., Khorinko A., Prokopenko T., Sakayeva D., Borisov V., Gurov S., Ivanov R., Salafet O., Marenich A., Reutova E., Sheveleva L., Karaseva N., Bogdanova N., Uskov D., Mukhametshina G., Tuzikov S., Khorinko A., Prokopenko T., Sakaeva D., Borisov V., Gurov S., Ivanov R., Salafet O.
EVALUATION OF THE EFFECTIVENESS OF CHEMOTHERAPY OF BREAST CANCER WITH LUNG METASTASES
Andreyashkina I., Plokhov V., Andreyashkina I., Plokhov V.
RENAL CELL CARCINOMA. PAST, PRESENT AND FUTURE
Yu Alyaev -., Shpot E., Alyaev Y., Shpot' E.
AVASTIN (BEVACIZUMAB) IN THE TREATMENT OF OVARIAN CANCER
Urmancheeva A., Urmancheeva A.
RAK MOLOChNOY ZhELEZY U MUZhChIN
Semiglazov V., Semiglazov V., Dashyan G., Paltuev R., Migmanova N., Shchedrin D., Grechukhina I., Bessonov A., Pen'kov K., Merabishvili V.
LEChENIE OPERABEL'NYKh I OTNOSITEL'NO OPERABEL'NYKh FORM RAKA MOLOChNOY ZhELEZY
Semiglazov V., Dashyan G., Semiglazov V., Donskikh R., Paltuev R.
FTORPIRIMIDINY V KhIMIOTERAPII DISSEMINIROVANNOGO KOLOREKTAL'NOGO RAKA U BOL'NYKh POZhILOGO VOZRASTA
Besova N.
Efficacy of ramucirumab in the second-line treatment of patients with disseminated gastric cancer in routine clinical practice in Russia (RAMSELGA observational study)
Besova N., Titova T., Tryakin A., Artamonova E., Stroyakovsky D., Perminova E., Yukalchuk D., Ponomarenko D., Belyak N., Orlova R., Teletaeva G., Ratner E., Mochalova A., Zhabina A., Gamayunov S., Smolin A., Povyshev A., Andrievskikh M., Stilidi I.
Frequency and spectrum of PIK3CA mutations in hormone-dependent HER2-negative breast cancer: a single-center experience
Romashkina N., Klishina M., Karabina E.
Prospective randomized phase III trial comparing FOLFIRINOX and mFOLFOX6 as first-line treatment for patients with disseminated gastric cancer: interim assessment of tolerability and toxicity
Gavrilova D., Besova N., Obarevich E., Makiev G., Tryakin A., Stilidi I.
Pelvic extrusion in patients with cervical cancer: clinical experience
Khakimov G., Khakimova G., Musurmonov K., Khakimova S., Orifjonova G.
Multiple thyroid carcinoma and other long-term endocrine consequences of chemoradiotherapy for medulloblastoma: a clinical case
Khruleva Y., Amergulov I., Likhodey N., Dzyuba A., Sych Y., Pavlova M.
Will our clinical practice change with the availability of new diagnostic methods, drug therapy and assessment of its effectiveness? Clinical case: hormone receptor-positive, HER2-negative metastatic breast cancer
Konstantinova M., Kuzina L.
Olaparib -modern approach to the treatment of BRCA-associated HER2-negative metastatic breast cancer. Clinical experience
Lubennikova E., Zhukova L., Gordeeva O., Drobot N., Kuznetsov A., Ganshina I.
Search for new prognostic and predictive markers of sensitivity to endocrine therapy, chemotherapy and immunotherapy of breast cancer
Semiglazov V., Pesotsky R., Tseluiko A., Dzhelyalova M., Apollonova V., Semiglazov V.
New possibilities of radionuclide therapy for patients with castration-resistant prostate cancer with bone metastases. The first experience of using radium-223 at the Chelyabinsk Regional Clinical Center for Oncology and Nuclear Medicine
Vasilieva E., Tolpeykina K., Vazhenin A., Chvanova K.
Prospects for the use of immunotherapy in the treatment of head and neck squamous cell carcinoma
Zagoruyko V., Semiglazova T., Radzhabova Z., Tkachenko E., Teletaeva G., Latipova D., Semenova A., Semiglazov V., Filatova L., Protsenko S.
New results of combination endocrinotherapy with ribocyclib
Kolyadina I.
Oral chemotherapy with vinorelbine for advanced breast cancer: its role in clinical practice
Sakaeva D., Nasretdinov A.
Non-small cell lung cancer complicated by bleeding: a clinical case
Budurova M., Kanzapetov M., Davydov M., Gerasimov S., Khaylenko V.
ANALYSIS OF INFLUENCE ON THE BUDGET OF THE RUSSIAN FEDERATION OF THE USE OF ORAL VINORELBINE FOR THE TREATMENT OF METASTATIC BREAST CANCER
Shabalkin P.
EXPERIENCE OF USE OF NEOADJUVANT DOSE-INTENSIVE CHEMOTHERAPY WITH DOXORUBICIN AND CISPLATIN IN COMBINED TREATMENT OF LOCALLY ADVANCED CERVICAL CANCER: PROSPECTIVE SINGLE-CENTER NON-RANDOMIZED CONTROLLED STUDY
Smirnova O., Bondarev N., Petrova A., Guseinov K., Mikaya N., Artemyeva A., Gorodnova T., Nekrasova E., Lavrynovych O., Bashlyk V., Nyuganen A., Abramova A., Sidoruk A., Ulrikh E., Semiglazova T., Urmancheeva A., Berlev I.
New molecular subtypes of non-small cell lung cancer and the possibilities of their treatment
Moiseenko F., Kudryavtsev A., Myslik A., Volkov N.
Neoadyavant therapy of non-small cell lung cancer: are there any perspectives?
Ragulin Y.
Possibilities of metabiotic therapy in the correction of gastrointestinal symptoms and violations of intestinal microbiota in patients with lung cancer during chemotherapy
Serkova M., Avalueva E., Orlov S.
WHETHER PRIMARY TUMOR LOCALIZATION IS IMPORTANT FOR THE PREDICTION OF DRUG TREATMENT OF METASTATIC COLON CANCER?
Dobrova N., Borisova E., Gutorov S., Abramov M.
ROLE OF NEW ANTIANGIOGENIC DRUGS IN THE SECOND-LINE TREATMENT OF NON-SMALL-CELL LUNG CANCER
Semenova A., Protsenko S., Novik A., Latipova D., Teletayeva G., Semiglazova T.
PLACE OF LAPATINIB IN THE THERAPY OF HER2-POSITIVE BREAST CANCER
Zhukova L., Ganshina I., Zaitsev V., Stepanchenko M.
Struktura slizistoy obolochki zheludka u bol'nykh rakom zheludka v Respublike Khakasiya
Tsukanov V., Kasparov E., Butorin N., Shtygasheva O., Vasyutin A., Amel'chugova O., Tonkikh Y., Bronnikova E.
KOMPLEKSNAYa TERAPIYa HER2-POZITIVNOGO RAKA MOLOChNOY ZhELEZY
Semiglazov V., Semiglazov V., Nikolaev K., Dashyan G., Paltuev R.
PERSPEKTIVY PRIMENENIYa S-1 V LEChENII BOL'NYKh RAKOM ZhELUDKA
Lud A., Abramov M., Meshcheryakov A.
NOVYE PERSPEKTIVNYE PREPARATY DLYa LEChENIYa HER2-POZITIVNOGO RAKA MOLOChNOY ZhELEZY
Gorbunova V.
Znachenie molekulyarnykh markerov pri vybore neoad\"yuvantnoy khimioterapii mestno-rasprostranennogo raka molochnoy zhelezy
Semiglazova T., Semiglazov V., Filatova L., Krivorot'ko P., Klimenko V., Ivanov V., Novikov S., Gershanovich M., Imyanitov E., Semiglazov V.
NASTOYaShchEE I BUDUShchEE TARGETNOY TERAPII V PERVOY LINII LEChENIYa RAKA YaIChNIKOV
Tyulyandina A.
Chemotherapy of head and neck squamous cell carcinoma (HNSCC)
Romanov I.
LOKOREGIONARNYE INTERVENTsIONNORADIOLOGIChESKIE TEKhNOLOGII V LEChENII GEPATOTsELLYuLYaRNOGO RAKA
Dolgushin B., Virshke E., Kosyrev V., Martynkov D., Trofimov I., Breder V.
SEARCH FOR MARKERS OF EFFICIENCY OF BEVACIZUMAB IN METASTATIC COLORECTAL CANCER
Gutorov S., Borisova E., Chichikov E., Denisenko A., Borisova Y., Chichikov Y., Denisenko A., Gutorov S.
BONE METABOLISM AND EFFECTIVENESS OF ZOLEDRONIC ACID IN LOCALLY ADVANCED AND DISSEMINATED PROSTATE CANCER
Glybochko P., Alyaev Y., Vinarov A., Demidko Y., Zelenova O., Shpot' E., Glybochko P., Alyaev Y., Vinarov A., Demidko Y., Zelenova O., Shpot Y.
CONFERENCE OF RENAL CANCER EXPERTS: A REVIEW OF MATERIALS
Volkova M., Volkova M.
EFFECTIVENESS OF AFINITOR® (EVEROLIMUS) FOR METASTATIC KIDNEY CANCER
Borisov V., Borisov V.
NANOTEKhNOLOGII V DIAGNOSTIKE I LEChENII ZLOKAChESTVENNYKh OPUKhOLEY
Semiglazov V., Paltuev R., Semiglazov V., Dashyan G., Bessonov A., Pen'kov K., Vasil'ev A.
SUNITINIB (SUTENT) V PERVOY LINII LEChENIYa METASTATIChESKOGO RAKA POChKI
Gutorov S., Borisova E., Lichinitser M.
NEOAD\"YuVANTNAYa ENDOKRINOTERAPIYa RAKA MOLOChNOY ZhELEZY
Semiglazov V., Semiglazov V., Ivanov V.
Approaches to the diagnosis and treatment of patients with stage III–IV non-small cell lung cancer in Russia. Preliminary results of a retrospective multicenter non-interventional observational study
Reutova E., Laktionov K.
Trastuzumab deruxtecan in the treatment of breast cancer
Semiglazov V., Krivorotko P., Bekkeldieva N., Gorina A., Komyakhov A., Paltuev R., Tabagua T., Ereshenko S.
Reconstructive plastic surgery of the breast using autogenous tissue. Historical aspects
Khakimova S., Zikiryakhodzhaev A., Kaprin A., Khakimova G., Onofriychuk I., Rasskazova E., Sukhotko A., Vlasova M., Bosieva A., Tokaev V.
Lorlatinib in the treatment of ALK-positive non-small cell lung cancer
Gordeeva O., Meshcheryakova N., Meshcheryakov A.
Pathological regression as an indicator of the effectiveness of perioperative FLOT/FOLFOX in patients with resectable gastric cancer
Belyak N., Orlova R., Kutukova S., Pelipas Y., Androsova A., Zhukova N.
Clinical case of treatment of patient with HRD-positive ovarian cancer
Khokhlova S.
Effectiveness of a shortened cycle of monoimmunotherapy in non-small cell lung cancer
Artemieva E., Moiseenko F., Volkov N., Egorenkov V., Abduloeva N., Bogdanov A., Zhabina A., Levchenko N., Moiseenko V.
Potentials for the use of aflibercept in the treatment of patients with metastatic colorectal cancer
Vladimirova L., Abramova N., Popova I., Storozhakova A., Novoselova K., Tikhanovskaya N., Ryadinskaya L., Lyanova A., Myagkova V., Teplyakova M., Kabanov S., Kalabanova E., Samaneva N., Tishina A., Strakhova L., Yezhova M.
New possibilities for conservative management of patients with HPV-associated diseases of the cervix of the uterus
Bebneva T., Maltseva L.
Interim assesment of the results of a clinical study of the regularities of changes in the patterns of lipid peroxidation -antioxidant defence in stomach cancer
Smirnova O., Tsukanov V., Modestov A., Sinyakov A., Moskalenko O., Elmanova N., Ovcharenko E., Titova N.
Modern immunotherapy for kidney cancer
Protsenko S., Semenova А., Oganesyan A., Anokhina E., Novik A.
Efficacy and safety of therapy with biosimilar bevacizumab in the treatment of patients with metastatic colon cancer -a series of clinical observations
Fedyanin M., Elsnukaeva K., Pokataev I., Sekhina O., Chekini D., Bulanov A., Tryakin A., Tyulyandin S.
EXPERIENCE OF PERSONALIZED APPOINTMENT OF NEOADJUVANT CHEMOTHERAPY FOR PATIENT WITH BREAST CANCER: A PROSPECTIVE STUDY
Slonimskaya E., Kazantseva P., Litviakov N., Tsyganov M., Ibragimova M., Doroshenko A., Vernadsky R., Vostrikova M., Lushnikova N.
BARRETT'S ESOPHAGUS WITH LOW-GRADE DYSPLASIA: A NEW LOOK AT THE PROBLEM
Bakulin I., Belousova L.
Olaparib - promising direction in therapy in BRCA-associated tumors
Abramov M., Chichikov E., Borisova E., Gutorov S.
Long-term results of combined treatment of colorectal cancer patients with liver metastases
Chernoglazova E., Vyshinskaya G., Sagaidak I., Rotobelskaya L., Abramov M., Filonenko D.
PROSTATE-SPECIFIC ANTIGEN AS A CRITERION OF PROSTATE CANCER PROGRESSION AFTER RADICAL PROSTATECTOMY
Varlamov I., Varlamov S., Lazarev A.
APPLICATION OF REPLACEMENT THERAPY WITH PANCREATIN PREPARATIONS IN PATIENTS WITH PANCREATIC CANCER
Kucheryavy Y., Andreev D.
NEOADJUVANT TREATMENT OF HER2-POSITIVE BREAST CANCER
Semiglazov V., Semiglazov V., Dashyan G., Krivorotko P., Nikolaev K., Semiglazova T., Komyakhov A., Bessonov A., Donskikh R., Paltuev R., Zernov K.
Prognoz bol'nykh kolorektal'nym rakom pri ozhirenii
Solodkiy V., Chkhikvadze V., Stanoevich U., Dekhissi E.
H. PYLORI-INFEKTsIYa: SOVREMENNYE REKOMENDATsII PO DIAGNOSTIKE I LEChENIYu
Gratsianskaya A.
LAPATINIB PRI RAKE MOLOChNOY ZhELEZY
Fray I., Perevodchikova N.
METODOLOGIChESKIE ASPEKTY MORFOLOGIChESKOY DIAGNOSTIKI I OTsENKI LEChEBNOGO PATOMORFOZA TROYNOGO NEGATIVNOGO RAKA MOLOChNOY ZhELEZY
Andreeva Y., Zavalishina L., Danilova N., Ilatovskaya M., Frank G.
101 - 200 de 317 resultados << < 1 2 3 4 > >> 
Dicas:
  • Palavras-chave são sensíveis a maiúsculas
  • Preposições e conjunções ingleses são ignoradas
  • Busca é feita por todos os palavras-chave (agente AND experimentador) por omissão
  • Use OR para pesquisar um termo exato, ex.: educação OR formação
  • Use parênteses para criar frases complexas, ex.: arquivo de ((revistas OR conferências) NOT teses)
  • Para pesquisar uma frase precisa use aspas duplas, ex.: "investigações científicas"
  • Exclua uma palavra utilizando o sinal - (hífen) ou operador NOT; ex.: concurso-de beleza ou concurso NOT de beleza
  • Use * como caractere-coringa, ex.: científic* recuperará as palavras "científico", "científicos", etc.